{"id":"W4319302851","doi":"10.1016/j.jacc.2022.11.041","title":"P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions","year":2023,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"Eisai; Abiomed; Osprey Medical; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Eli Lilly and Company; AstraZeneca; CSL Behring; Janssen Pharmaceuticals; Gilead Sciences; Edwards Lifesciences; Amgen; Pfizer; Bayer; Daiichi Sankyo Europe; University of Bern; Sanofi; Abbott Vascular; Abbott Laboratories","keywords":"Conventional PCI; Medicine; Percutaneous coronary intervention; Internal medicine; Clinical endpoint; Cardiology; P2Y12; Clopidogrel; Stent; Myocardial infarction; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007392608,0.0005773268,0.006413029,0.0004860172,0.0001057965,0.0000113922,0.0005622696,0.0002533216,0.0001429196],"category_scores_gemma":[0.0001256816,0.0003136853,0.009526036,0.0009290372,0.001027472,0.00005714011,0.0001502166,0.0008047492,0.00002031861],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00016772,"about_ca_system_score_gemma":0.0009827641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004265905,"about_ca_topic_score_gemma":0.000002372234,"domain_scores_codex":[0.9954082,0.001425498,0.001779539,0.0003497476,0.000620208,0.0004167696],"domain_scores_gemma":[0.9959695,0.0005238362,0.002130953,0.0008335348,0.0003489922,0.0001932001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01849477,0.0004192185,0.0006895289,0.007611354,0.0517086,0.04323693,0.00007551608,0.00005825442,0.0001041776,0.00002245846,0.02517075,0.8524084],"study_design_scores_gemma":[0.001856239,0.002963749,0.00144078,0.008102925,0.004212565,0.1234292,0.0002275902,0.000001497295,0.000004086069,0.00002585059,0.857406,0.0003295176],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03121808,0.9655371,0.00006508004,0.0002319445,0.0009301358,0.001105477,0.000813027,0.00003289427,0.00006621322],"genre_scores_gemma":[0.01742055,0.9798641,0.0001994104,0.000273704,0.001430491,0.00003431739,0.0000222706,0.000147213,0.0006079834],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8520789,"threshold_uncertainty_score":0.9999315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0823996957005993,"score_gpt":0.3608033159167613,"score_spread":0.2784036202161621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}